POSC63 Cost-Effectiveness of Non-Statin Lipid-Modifying Agents for Primary and Secondary Prevention of Cardiovascular Disease Among Patients with Type 2 Diabetes Mellitus: A Systematic Review
Abstract
Authors
D Abushanab D Al-Badriyeh C Marquina C Bailey M Jaam D Liew Z Ademi